Liawatidewi Yakob Insider Trades

Insider Trading History

Track insider trading activity for Liawatidewi Yakob. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $2.28M 121,892 shares
Last Trade
Mar 15, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.8k 1,033 shares
$18.18
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $2.3M 122,925 shares
Last Trade
Mar 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$35.4k 1,870 shares
$18.91
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $2.33M 124,795 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.09M 108,576 shares
$19.21
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.67M 89,345 shares
Last Trade
Mar 06, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$22.1k 1,144 shares
$19.34
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.69M 90,489 shares
Last Trade
Mar 04, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$19.3k 965 shares
$19.96
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.7M 90,909 shares
Last Trade
Mar 17, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$47.9k 1,731 shares
$27.69
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.73M 92,640 shares
Last Trade
Mar 15, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$27.5k 1,031 shares
$26.66
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.75M 93,671 shares
Last Trade
Mar 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.26M 44,253 shares
$28.41
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.36M 72,834 shares
Last Trade
Mar 06, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$32.3k 1,141 shares
$28.32
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.5M 80,152 shares
Last Trade
Nov 06, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$278k 5,214 shares
$53.40
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.4M 74,938 shares
Last Trade
Nov 06, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$271k 5,214 shares
$52.05
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $205k 10,962 shares
Last Trade
Nov 06, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$278k 5,214 shares
$53.40
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.4M 74,938 shares
Last Trade
Jun 04, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.5k 272 shares
$42.22
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.4M 74,778 shares
Last Trade
Mar 17, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$74.3k 1,726 shares
$43.05
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.43M 76,504 shares
Last Trade
Mar 16, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$71.9k 1,671 shares
$43.05
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.46M 78,175 shares
Last Trade
Mar 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$44.2k 1,027 shares
$43.05
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.48M 79,202 shares
Last Trade
Mar 06, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$56.5k 1,221 shares
$46.31
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP CORP ADMIN CENTER
Holding Value $1.5M 80,423 shares
Last Trade
Mar 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06M 22,655 shares
$46.68
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP Corp Admin Center
Holding Value $302k 16,176 shares
Last Trade
Aug 28, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.53M 28,816 shares
$52.95
$18.70
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals AMPH
EVP Corp Admin Center
Holding Value $1.3M 69,669 shares
Last Trade
Aug 28, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.53M 28,816 shares
$53.13
$18.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up